SC
XYL icon

Sculptor Capital’s Xylem XYL Stock Holding History

Sculptor Capital’s Portfolio XYL Stock Details XYL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,299,345
Closed -$129M – 851
2014
Q2 		$129M Sell
3,299,345
-511,663
-13% -$19.1M 0.38% 69
2014
Q1 		$139M Buy
+3,811,008
New +$139M 0.46% 58

Other funds holding XYL

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return
SC
Sasco Capital Fairfield, Connecticut $668M AUM 12.79% 1-Year Est. Return

Sculptor Capital's XYL Position: Q3 2014 in Review

Sculptor Capital sold out of Xylem (XYL) in Q3 2014, closing a stake of 3,299,345 shares — an estimated $129M sold.

Sculptor Capital first reported a position in XYL in Q1 2014 and held it in 2 quarters. The position peaked at $139M in Q1 2014. 439 funds tracked by Wall St. Rank hold XYL as of Q3 2014.

  • Sculptor Capital reported no remaining Xylem position as of Q3 2014 after selling out during the quarter.
  • Sculptor Capital sold 3,299,345 Xylem shares in Q3 2014, an estimated $129M.
  • Sculptor Capital first reported a position in Xylem in Q1 2014 and held it in 2 quarters.
  • Sculptor Capital's Xylem position peaked at $139M in Q1 2014.
  • 439 funds tracked by Wall St. Rank held Xylem as of Q3 2014.

Based on Sculptor Capital's 13F filing for Q3 2014, filed 14 Nov 2014.